T. Rowe Price Associates’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $16.5M | Sell |
|
|||||
|
2018
Q2 | $13M | Sell |
|
|||||
|
2018
Q1 | $17.3M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $113K | Hold |
|
|||||
|
2017
Q2 | $116K | Sell |
|
|||||
|
2017
Q1 | $295K | Hold |
|
|||||
|
2016
Q4 | $289K | Sell |
|
|||||
|
2016
Q3 | $24.3M | Sell |
|
|||||
|
2016
Q2 | $38M | Buy |
|
|||||
|
2016
Q1 | $37M | Buy |
|
|||||
|
2015
Q4 | $43.8M | Buy |
|
|||||
|
2015
Q3 | $28M | Buy |
|
|||||
|
2015
Q2 | $1.8M | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $90K | Sell |
|
|||||
|
2013
Q4 | $166K | Sell |
|
|||||
|
2013
Q3 | $183K | Sell |
|
|||||
|
2013
Q2 | $16.6M | Buy |
|